---
title: "NCAB Group Sets April 23 Date for First-Quarter 2026 Results Presentation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282004384.md"
description: "NCAB Group Sets April 23 Date for First-Quarter 2026 Results Presentation"
datetime: "2026-04-08T08:38:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282004384.md)
  - [en](https://longbridge.com/en/news/282004384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282004384.md)
---

# NCAB Group Sets April 23 Date for First-Quarter 2026 Results Presentation

NCAB Group Sets April 23 Date for First-Quarter 2026 Results Presentation

### Related Stocks

- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BCAB.US](https://longbridge.com/en/quote/BCAB.US.md)

## Related News & Research

- [BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts | ONC Stock News](https://longbridge.com/en/news/287198763.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO](https://longbridge.com/en/news/287276384.md)
- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline | LIMN Stock News](https://longbridge.com/en/news/287218720.md)